Team

Ariel is a junior at Duke University majoring in biotechnology with concentrations in finance and regulatory policy. Previously, Ariel interned at 12 West Capital, a long/short equity hedge fund and IDEA Fund Partners (a local VC firm), and is currently working at Raymond James conducting biotechnology equity research. Ariel has an extensive research background in fields of DNA damage and repair viral vector platform development through research fellowships at the NIH and Gene Therapy Center. He is currently working on developing gene-editing platforms for treatment of human genetic diseases at the Duke Department of Biomedical Engineering. A former two-sport athlete and Foot Locker Scholar-Athlete of the Year awardee, Ariel enjoys staying active and working out in his free time.